… ProQR to Present at Upcoming Scientific Conferences LEIDEN, Netherlands and CAMBRIDGE, … Presentation at the 3 rd Annual Ophthalmic Drugs Conference A presentation will be delivered by Aniz Girach, …
… ProQR to Present at Three Scientific Conferences in April LEIDEN, Netherlands and … (ASGCT). Retinal Cell & Gene Therapy Innovation Summit The conference is being held on Friday, April 26, 2019 in …
… Epidermolysis Bullosa and will Present Data at two Scientific Conferences Key Updates ProQR’s drug candidate … conferences in Salzburg, Austria – EB2017 Research Conference and ESDR Meeting. DEB is a severe genetic skin …
… and presented positive pre-clinical data at two European scientific conferences. WINGS, a Phase 1/2 safety and … F508del mutation were presented at the North American CF conference. A Phase 2 study is currently being designed and …
Initial pipeline programs with liver delivery to address Cholestatic Diseases targeting NTCP and Cardiovascular Disease targeting B4GALT1; initiation of clinical trials anticipated in late 2024/early 2025
Axiomer activity demonstrated across multiple preclinical in vitro
… products, if any. Financial details were not disclosed. Scientific Updates Data on the ProQR portfolio were presented at three scientific conferences in April and May. One abstract was …
